GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (STU:NG2) » Definitions » Price-to-Owner-Earnings

Neogen (STU:NG2) Price-to-Owner-Earnings : (As of Sep. 23, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Neogen Price-to-Owner-Earnings?

As of today (2024-09-23), Neogen's share price is €15.70. Neogen does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Neogen's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Neogen was 369.20. The lowest was 47.38. And the median was 68.95.


STU:NG2's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 28.94
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-09-23), Neogen's share price is €15.70. Neogen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2024 was €-0.04. Therefore, Neogen's PE Ratio for today is At Loss.

As of today (2024-09-23), Neogen's share price is €15.70. Neogen's EPS without NRI for the trailing twelve months (TTM) ended in was €0.20. Therefore, Neogen's PE Ratio without NRI for today is 77.72.

During the past 13 years, Neogen's highest PE Ratio without NRI was 86.00. The lowest was 32.16. And the median was 59.11.


Neogen Price-to-Owner-Earnings Historical Data

The historical data trend for Neogen's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Price-to-Owner-Earnings Chart

Neogen Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.62 84.66 63.59 - -

Neogen Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 190.91 66.52 94.71 -

Competitive Comparison of Neogen's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Neogen's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Neogen's Price-to-Owner-Earnings falls into.



Neogen Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Neogen's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=15.70/-0.15
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neogen  (STU:NG2) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Neogen Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Neogen's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Neogen Business Description

Traded in Other Exchanges
Address
620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Neogen Headlines

No Headlines